Elementis (ELM) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
16 Nov, 2025Executive summary
Delivered strong H1 2025 financial performance despite soft demand, with adjusted operating profit up 6–7% to $65m and margins improving to 21–21.2%, keeping full-year expectations on track.
Completed the sale of the Talc business, streamlining the portfolio, accelerating CMD targets a year ahead, and enabling a $50m share buyback.
Launched the Elevate Elementis strategy, focusing on specialty additives, sustainable growth, and new medium-term financial targets.
Early delivery of 2026 CMD financial targets, including margin and cash conversion improvements.
Net debt reduced by 36% to $125m, with net debt/EBITDA at 0.9x and a strong balance sheet.
Financial highlights
H1 2025 revenue was $308m, down 1–2% year-over-year on a constant currency basis; adjusted operating profit rose 6–7% to $65m.
Adjusted operating margin improved to 21–21.2%, up 160 bps year-over-year.
Adjusted EPS increased 19% to 6.8 cents; interim dividend declared at 1.3 cents per share, up 18%.
Free cash flow for H1 2025 was $16m, with $53m–$55m proceeds from the Talc disposal.
Adjusted EBITDA for the last 12 months reached $145.3m; contribution margin improved to 52.8%.
Outlook and guidance
On track to deliver full-year expectations, with resilient performance expected in coatings and continued growth in personal care.
Full-year adjusted operating profit expected to be in line with market consensus ($126m, range $122–129m).
Medium-term targets: mid-single-digit revenue growth, adjusted operating margin above 23%, cash conversion over 90%, and ROCE above 30%.
Additional $10m in cost savings identified for the remainder of this year and next; on track to deliver $12m savings in 2025.
2025 guidance includes adjusted effective tax rate of ~26%, net finance costs of ~$25m, and capex at 3% of sales.
Latest events from Elementis
- Strong profit and margin growth achieved amid portfolio transformation and innovation focus.ELM
H2 20255 Mar 2026 - Adjusted profit up 24%, margin at 17%, and Talc review after $66m impairment.ELM
H1 20242 Feb 2026 - Adjusted operating profit and margins improved year-over-year, with strong cash flow and strategic actions.ELM
Q4 2025 TU21 Jan 2026 - Strong 2024 growth, margin expansion, and cost savings position for 2026 targets.ELM
H2 20242 Dec 2025 - Talc business sold for $121m, enabling $50m buyback and sharper specialty focus.ELM
Investor Update21 Nov 2025 - Q3 revenue up 2% year-over-year, guidance maintained, and key leadership transitions announced.ELM
Trading Update29 Oct 2025 - Resilient Q3 performance, steady margins, and full-year guidance reaffirmed.ELM
Trading Update13 Jun 2025 - Profit and margin growth achieved amid weak demand; cost savings and outlook on track.ELM
Trading Update6 Jun 2025